What is CME Group's stock-based comp?

CME Group (CME) reported stock-based comp of $21.8M in Q1 2026.

How has CME Group's stock-based comp changed year-over-year?

CME Group's stock-based comp increased by 2.8% year-over-year, from $21.2M to $21.8M.

What is the long-term trend for CME Group's stock-based comp?

Over 4 years (2021 to 2025), CME Group's stock-based comp has grown at a 6.0% compound annual growth rate (CAGR), from $75.2M to $94.8M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

CME Group CME Stock-Based Comp

Stock-Based Comp at other companies

MarketAxessMKTX

$9.15M+24.8%

Cboe Global MarketsCBOE

$12.9M+4.0%

Intercontinental ExchangeICE

$78M+36.8%

Coinbase Global, Inc.COIN

$248.06M+30.1%

Tradeweb Markets Inc.TW

$25.06M+12.9%

Nasdaq, Inc.NDAQ

$38M+8.6%

Other financials

Income statement

See full

Revenue$1.9B+14.5%

Operating income$1.3B+18.2%

Net income$1.2B+23.7%

EPS (diluted)$3.18+21.4%

Balance sheet

See full

Cash & equivalents$2.4B+70.2%

Total debt$3.7B-1.4%

Total equity$26.6B-1.5%

Total assets$201.99B+28.0%

Cash flow

See full

Operating cash flow$1.3B+12.8%

CapEx$21.8M+53.5%

Free cash flow$1.2B+12.3%

Valuation

See full

Market cap$79.85B-18.3%

Enterprise value$81.2B-18.5%

P/E18.6×-7.4×

P/S11.8×-3.4×

Profitability

See full

Operating margin65.6%+0.6pp

Net margin63.6%+5.9pp

FCF margin64.1%+3.2pp

Returns & leverage

See full

Return on equity16%+2.6pp

Debt / equity0.1×0.0×

Current ratio1×0.0×

Where this comes from

Reported directly by CME Group in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: CME Group’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about CME Group's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CME Group's stock-based comp?: CME Group (CME) reported stock-based comp of $21.8M in Q1 2026.
How has CME Group's stock-based comp changed year-over-year?: CME Group's stock-based comp increased by 2.8% year-over-year, from $21.2M to $21.8M.
What is the long-term trend for CME Group's stock-based comp?: Over 4 years (2021 to 2025), CME Group's stock-based comp has grown at a 6.0% compound annual growth rate (CAGR), from $75.2M to $94.8M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.